Health
Existing drug masitinib identified as potential inhibitor of SARS-CoV-2 – News-Medical.Net
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COV…
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
The drug, which is called masitinib, potently inhibited the main viral protease 3CLpro that SARs-CoV-2 relies on for infection to proceed once the viral genome has entered the host cell cytoplasm.
The study showed that masitinib di…
-
Noosa News10 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News11 hours agoMotorcyclist dies in crash with truck
-
Noosa News11 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General16 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging